StockWatch: Illumina Shares Steady as Icahn Escalates Proxy Fight
Illumina stock hardly budged despite a regulatory setback for the company and escalating criticism from activist investor Carl Icahn.
Stay updated with breaking news from Structured Alpha. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Illumina stock hardly budged despite a regulatory setback for the company and escalating criticism from activist investor Carl Icahn.
Wall Street closed on a mixed note on Wednesday, with the tech-heavy Nasdaq suffering its third consecutive loss.
/PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: LMNL) ("Liminal BioSciences" or the "Company"), confirms that following close of markets on April 4, 2023, the...
LAVAL, QC and CAMBRIDGE, England, April 5, 2023 /PRNewswire/ -- Liminal BioSciences Inc. (NASDAQ: LMNL) ("Liminal BioSciences" or the "Company"), confirms that following close of markets on
A look at North American equities heading in both directions